Abstract
A series of iodinated benzoboroxoles was designed and synthesized by using a successive metal–iodine exchange reaction of 3,4,5‐triiodoanisole. The reactivity and regioselectivity of the metal‐iodine exchange are remarkably controlled and provide the iodinated products in good yields. The synthesized iodobenzoboroxoles were screened for in vitro antimicrobial activity against two Gram‐positive strains of bacteria, Micrococcus luteus (ATCC 9341) and Bacillus cereus (ATCC 11778), and two Gram‐negative strains, Escherichia coli (ATCC 25922) and Serratia marcescens (ATCC 27117), by using a well‐diffusion assay and dilution methods. The in vitro antimicrobial evaluation indicated that 4‐iodo‐6‐methoxybenzo[c][1,2]oxaborol‐1(3H)‐ol (compound 24) possesses the most‐potent antibacterial activity against Gram‐positive strains with a minimum inhibitory concentration (MIC) of 0.016 and 0.013 mg/mL for Micrococcus luteus and Bacillus cereus, respectively. This report discloses a two‐step protocol for the synthesis of hitherto unknown 4‐iodobenzoboroxole and 7‐iodobenzoboroxole derivatives that is efficient, general in scope and scalable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
